Lotte Biologics signs antibody drug CMO deal with UK’s Ottimo Pharma

BOSTON – Lotte Biologics Co. has signed a deal to manufacture an antibody therapy for British biotech startup Ottimo Pharma as the South Korea...

CJ CGV under pressure to shed China, Vietnam cinema assets

MBK Partners and Mirae Asset Securities Co. are considering divesting of their holdings in CGI Holdings Co., which oversees CJ CGV Co.’s multi...

President Lee: Businesses at center of policy priorities for economic growth

South Korean President Lee Jae-myung on Friday pledged strong government support for the country’s businesses, while emphasizing the need for ...

CJ Foodville goes global from in-flight meals to Starbucks bread

CJ Foodville Co., a South Korean food company, is deepening its presence in Southeast Asia with premium bakery products, catering to airplane passen...

Samsung Biologics to spin off biosimilar unit Samsung Bioepis

Samsung Biologics Co., the world’s largest contract drugmaker, will undergo a strategic split to separate its contract development and manufac...

CJ CheilJedang to open $72 million dumpling plant in Japan

South Korea’s largest food company, CJ CheilJedang Corp., is shifting into high gear in its global expansion with a 100 billion won ($72 milli...

CJ CheilJedang scraps $3.5 bn green bio sale, shifts gears to expansion

CJ CheilJedang Corp., South Korea’s largest food and beverage company, said on Wednesday it has scrapped a planned sale of its green bio busin...

CJ CheilJedang scraps sale of Brazilian unit CJ Selecta to Bunge

CJ CheilJedang Corp., South Korea’s largest food company, has cancelled the sale of a 66% stake in Brazilian soybean crusher CJ Selecta S.A. a...

Celltrion unveils cancer medicine to expand new drug pipelines

South Korea’s leading biosimilar drug developer Celltrion Inc. on Sunday unveiled an anticancer medicine to expand new pipelines and accelerat...

Celltrion expands footprint in Latin America with flagship oncology drugs

South Korea’s biopharmaceutical giant Celltrion Inc. has solidified its presence in South America after winning supply contracts for its flags...

Celltrion wins Australian approval for eye, bone disease biosimilars

Celltrion Inc. said Wednesday it has received regulatory approval from Australia’s Therapeutic Goods Administration (TGA) for three biosimilar...

ABL Bio lands $2.8 billion license-out deal with GSK

ABL Bio Inc., a South Korean biotech company, will license out its proprietary blood-brain barrier shuttle platform, called the Grabody-B, to UK-bas...

Celltrion to sell autoimmune drug Stelara biosimilar at Costco in US

South Korea’s leading biosimilar drug developer Celltrion Inc. said on Monday it is set to sell Steqeyma, a biosimilar to autoimmune disease t...

SillaJen: First to use lab-grown human tissue to find best cancer drug dose

South Korean biotechnology firm SillaJen Inc. is pioneering a new approach to determine the best dose for a cancer drug combination in clinical tria...

Red flags raised even before Homeplus crisis: Sales fall, credit ratings cut

Even before South Korea’s second-largest hypermarket chain Homeplus Co. was put under court receivership due to its worsening financial woes, ...

K-beauty shake-up: APR, Shinsegae rise as Aekyung declines

South Korea’s beauty industry is undergoing a major reshuffle, with new players rising to prominence while established giants face growing com...

MBK Partners poised to acquire CJ Cheiljedang’s $3.5 billion bio business

North Asia-focused private equity firm MBK Partners is on the verge of clinching a major acquisition deal by offering a higher bid than other conten...

Chong Kun Dang to build new plant for foray into biologics market

Chong Kun Dang Pharmaceutical Corp. is discussing building a research center and a plant in Siheung, about 30 kilometers southwest of Seoul, with th...

Celltrion wins EU approval for autoimmune disease treatment Avtozma

Celltrion Inc.’s Avtozma, a biosimilar to Roche’s autoimmune disease treatment Actemra, has won approval from the European Commission, f...

Beauty giant CJ Olive Young to buy Seoul office building for $472 mn

CJ Olive Young Corp., South Korea’s top beauty store chain, has been given priority rights to buy an office building in Seoul for about 680 bi...

MBK Partners, 2 Chinese firms vie for CJ Cheiljedang’s $4 bn bio business

North Asia-focused private equity firm MBK Partners and two leading Chinese biotechnology firms are vying for management control of CJ Cheiljedang C...

Korea’s beauty retailer CJ Olive Young to open first US offline outlet

CJ Olive Young Corp., South Korea’s top beauty store chain, said on Tuesday it has set up a US business entity in Los Angeles to enhance its p...

Lotte Biologics eyes first ADC CDMO order in 2025

SAN FRANCISCO -- Lotte Biologics Co., the drug consignment development and production unit of South Korean conglomerate Lotte Group, will seek to wi...

Celltrion seeks large-scale M&A in Q4, eyes 2027 Nasdaq debut

SAN FRANCISCO – South Korea’s leading biosimilar drug developer Celltrion Inc. seeks to acquire a domestic health food maker as early as...

SK Biopharmaceuticals, Eurofarma to set up AI epilepsy platform JV in US

South Korea’s SK Biopharmaceuticals Co. has signed a deal with Brazil’s Eurofarma Laboratórios S.A. to establish a joint venture ...

Samsung Biologics signs initial deal with LigaChem Bio on ADC production

Samsung Biologics Co., the world’s largest contract drugmaker, said on Thursday it has signed an initial agreement with LigaChem Biosciences I...

Yuhan’s lung cancer drug gets OK in Europe

Leclaza (ingredient: lazertinib), a new lung cancer treatment developed by South Korea’s Yuhan Corp. secured approval from the European Commis...

Boryung, Lotus Pharma signs CDMO deal on anticancer injection

South Korea's Boryung Corp. said on Thursday it signed a contract with Lotus Pharmaceutical, a Taiwanese oncology firm, for contract development and...

HD Hyundai Oilbank supplies bio VLSFO to Yangming

HD Hyundai Oilbank Co., a South Korean crude oil refiner backed by Saudi Aramco, said on Thursday it started to supply Taiwan-based Yang Ming Marine...

SK Biopharm submits NDA of epilepsy drug to China

South Korea's SK Biopharmaceuticals Co. said on Tuesday it submitted the new drug application (NDA) for its flagship epilepsy drug Cenobamate to Chi...